The prevention and treatment of hospital-acquired infections depends less on procedures and more on culture, leadership, and organizational commitment, say five healthcare leaders who recently joined with HealthLeaders Media for an in-depth conversation.
Four legislative actions could ease the burden of high-cost prescription drugs—such as a $1,000-per-pill hepatitis C drug—on Medicare, the public, and commercial payers, says U.S. Rep. Henry Waxman.
More News & Analysis
- Study Puts Spotlight on Preventing Fall-Related Injuries
- Contradictory Obamacare Rulings Issued by Appellate Courts
- Roundtable: Life After a Healthcare Organization Acquisition
- CVS Ramps Up Retail Clinics with Provider Affiliations